IFNA1 and systemic lupus erythematosus: Furthermore, mice deficient in the IFNα/β receptor have been shown to exhibit reduced signs and symptoms of SLE (23), and the IFNα kinoid vaccine prevents clinical manifestations in a lupus flare model (24).